Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
A Case Study Report: Zoledronic Acid Induced Jaw Osteonecrosis in Patient with Bone Metastasis, A Relatively Rare Side Effect
View through CrossRef
Jaw osteonecrosis (JON) is an extraordinary reaction seen in sufferers receiving bisphosphonate remedy for bone retention for the duration of cases of bone metastasis. Nitrogen-based totally bisphosphonates (NBBP) similar to Zoledronic acid whilst injected with intravenous (IV) have a stronger potential to enhance jaw osteonecrosis in comparison with oral treatment. To get the fine healing consequences and to be affected person, it's miles best to apply zoledronic acid every year. This paper reviews the case of an eighty-year-vintage woman affected by endometrial cancer with bone metastasis advanced through Jaw osteonecrosis (JON) after consecutive cycles to offer her Zoledronic acid. Exam reveals early signs and symptoms of Jaw osteonecrosis (JON) in a doctor's record she became tested and discontinued giving zoledronate. Jaw osteonecrosis (JON) happens due to zoledronate perennial infusions. The chance increases for humans with bad oral hygiene due to infections.
Title: A Case Study Report: Zoledronic Acid Induced Jaw Osteonecrosis in Patient with Bone Metastasis, A Relatively Rare Side Effect
Description:
Jaw osteonecrosis (JON) is an extraordinary reaction seen in sufferers receiving bisphosphonate remedy for bone retention for the duration of cases of bone metastasis.
Nitrogen-based totally bisphosphonates (NBBP) similar to Zoledronic acid whilst injected with intravenous (IV) have a stronger potential to enhance jaw osteonecrosis in comparison with oral treatment.
To get the fine healing consequences and to be affected person, it's miles best to apply zoledronic acid every year.
This paper reviews the case of an eighty-year-vintage woman affected by endometrial cancer with bone metastasis advanced through Jaw osteonecrosis (JON) after consecutive cycles to offer her Zoledronic acid.
Exam reveals early signs and symptoms of Jaw osteonecrosis (JON) in a doctor's record she became tested and discontinued giving zoledronate.
Jaw osteonecrosis (JON) happens due to zoledronate perennial infusions.
The chance increases for humans with bad oral hygiene due to infections.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Asymptomatic Osteonecrosis of the Trochlea in an Adolescent: A Case Report
Asymptomatic Osteonecrosis of the Trochlea in an Adolescent: A Case Report
Abstract
Introduction
Osteonecrosis, also known as avascular necrosis, aseptic necrosis, or ischemic necrosis, results from a temporary or permanent halt in blood flow to a portion...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Zoledronic Acid Is Not Equally Potent on Osteoclasts Generated From Different Individuals
Zoledronic Acid Is Not Equally Potent on Osteoclasts Generated From Different Individuals
ABSTRACT
Zoledronic acid is a bisphosphonate commonly used to treat bone diseases such as osteoporosis and cancer‐induced bone disease. Patie...
Local Administration of Zoledronic Acid for Giant Cell Tumor of Bone
Local Administration of Zoledronic Acid for Giant Cell Tumor of Bone
Giant cell tumor of bone is a locally aggressive tumor with a high local recurrence rate. Several adjuvant therapies have been employed to reduce the recurrence rate, but their eff...
How zoledronic acid improves osteoporosis by acting on osteoclasts
How zoledronic acid improves osteoporosis by acting on osteoclasts
Osteoporosis is called a silent disease, because it is difficult to detect until comprehensive examinations for osteoporosis are performed or osteoporotic fractures occur. Zoledron...